<it>Plasmodium vivax </it>trophozoites insensitive to chloroquine

<p>Abstract</p> <p>Background</p> <p><it>Plasmodium vivax </it>is a major cause of malaria and is still primarily treated with chloroquine. Chloroquine inhibits the polymerization of haem to inert haemozoin. Free haem monomers are thought to catalyze oxidati...

Full description

Bibliographic Details
Main Authors: Jaidee Anchalee, Travers Thomas, Kosaisavee Varakorn, Edstein Michael D, Lek-Uthai Usa, Suwanarusk Rossarin, Sharrock Wesley W, Sriprawat Kanlaya, Price Ric N, Nosten François, Russell Bruce
Format: Article
Language:English
Published: BMC 2008-05-01
Series:Malaria Journal
Online Access:http://www.malariajournal.com/content/7/1/94
Description
Summary:<p>Abstract</p> <p>Background</p> <p><it>Plasmodium vivax </it>is a major cause of malaria and is still primarily treated with chloroquine. Chloroquine inhibits the polymerization of haem to inert haemozoin. Free haem monomers are thought to catalyze oxidative damage to the <it>Plasmodium </it>spp. trophozoite, the stage when haemoglobin catabolism is maximal. However preliminary <it>in vitro </it>observations on <it>P. vivax </it>clinical isolates suggest that only ring stages (early trophozoites) are sensitive to chloroquine. In this study, the stage specific action of chloroquine was investigated in synchronous cryopreserved isolates of <it>P. vivax</it>.</p> <p>Methods</p> <p>The <it>in vitro </it>chloroquine sensitivity of paired ring and trophozoite stages from 11 cryopreserved <it>P. vivax </it>clinical isolates from Thailand and two <it>Plasmodium falciparum </it>clones (chloroquine resistant K1 and chloroquine sensitive FC27) was measured using a modified WHO microtest method and fluorometric SYBR Green I Assay. The time each stage was exposed to chloroquine treatment was controlled by washing the chloroquine off at 20 hours after the beginning of treatment.</p> <p>Results</p> <p><it>Plasmodium vivax </it>isolates added to the assay at ring stage had significantly lower median IC<sub>50s </sub>to chloroquine than the same isolates added at trophozoite stage (median IC<sub>50 </sub>12 nM vs 415 nM <it>p </it>< 0.01). Although only 36% (4/11) of the SYBR Green I assays for <it>P. vivax </it>were successful, both microscopy and SYBR Green I assays indicated that only <it>P. vivax </it>trophozoites were able to develop to schizonts at chloroquine concentrations above 100 nM.</p> <p>Conclusion</p> <p>Data from this study confirms the diminished sensitivity of <it>P. vivax </it>trophozoites to chloroquine, the stage thought to be the target of this drug. These results raise important questions about the pharmacodynamic action of chloroquine, and highlight a fundamental difference in the activity of chloroquine between <it>P. vivax </it>and <it>P. falciparum</it>.</p>
ISSN:1475-2875